WASHINGTON — A senior White House official launched a targeted attack Tuesday against a drugmaker that was fighting the Medicare administration’s bargaining plan in court.
Christen Linke Young, deputy assistant to the chairman of the White House Domestic Policy Council for Health and Veterans Affairs, took on Bristol Myers Squibb, which makes the hit film Eliquis. Eliquis is one of 10 very expensive drugs offered by the federal program targeted first for negotiated prices.
“The maker of this drug spent most of 2020 in court trying to fend off generic competition,” she said Tuesday at a STAT event. Generic drugmakers sued BMS in 2019 to challenge the drug’s patents.
